BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33664816)

  • 1. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Apr; 21(4):252. PubMed ID: 33664816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRN is a prognostic biomarker and correlated with immune infiltration in glioma: A study based on TCGA data.
    Xu SM; Xiao HY; Hu ZX; Zhong XF; Zeng YJ; Wu YX; Li D; Song T
    Front Oncol; 2023; 13():1162983. PubMed ID: 37091137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses.
    Liu M; Yu Y; Zhang Z; Chen Z; Chen B; Cheng Y; Wei Y; Li J; Shang H
    Ann Transl Med; 2021 Nov; 9(22):1657. PubMed ID: 34988166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Oncol Lett; 2021 Jan; 21(1):22. PubMed ID: 33240428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
    Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
    Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.
    Li Y; Ma K; Xie Q; Zhang X; Zhang X; Chen K; Kong L; Qian R
    Onco Targets Ther; 2021; 14():5183-5195. PubMed ID: 34737577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
    Cui G; Xiao Y
    Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma.
    Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z
    Front Genet; 2023; 14():1148126. PubMed ID: 37284062
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.
    Guo Q; Guan GF; Cheng W; Zou CY; Zhu C; Cheng P; Wu AH
    CNS Neurosci Ther; 2019 Mar; 25(3):343-354. PubMed ID: 30311408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased TRIM5 is associated with a poor prognosis and immune infiltration in glioma patients].
    Chen Y; Li Q; Zhang J; Gu R; Li K; Zhao G; Yuan H; Feng T; Ou D; Lin P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2020 Jun; 37(3):469-479. PubMed ID: 32597089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma.
    Chen Y; Pan Y; Gao H; Yi Y; Qin S; Ma F; Zhou X; Guan M
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12315-12332. PubMed ID: 37432454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas.
    Song ZB; Yang HP; Xu AQ; Zhan ZM; Song Y; Li ZY
    Chin Med J (Engl); 2020 Mar; 133(6):670-678. PubMed ID: 32197031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
    Lv S; Luo H; Huang K; Zhu X
    Med Sci Monit; 2020 Oct; 26():e926440. PubMed ID: 33085656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma.
    Liu Q; Wang R; Li Z; Peng Y; Qin W; Peng XM; Liu ZG
    Transl Cancer Res; 2023 May; 12(5):1073-1087. PubMed ID: 37304538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
    Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
    Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of Core Genes and Screening of Potential Targets in Glioblastoma Multiforme by Integrated Bioinformatic Analysis.
    Yang J; Yang Q
    Front Oncol; 2020; 10():615976. PubMed ID: 33718116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of
    Xu X; Zhong Z; Shao Y; Yi Y
    Front Genet; 2021; 12():679097. PubMed ID: 34220951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
    Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
    BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.